wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39177162-7BF9480A-E663-4D9A-BC62-239D40341B30
Q39177162-7BF9480A-E663-4D9A-BC62-239D40341B30
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39177162-7BF9480A-E663-4D9A-BC62-239D40341B30
Sarilumab: First Global Approval.
P2860
Q39177162-7BF9480A-E663-4D9A-BC62-239D40341B30
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39177162-7BF9480A-E663-4D9A-BC62-239D40341B30
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
23635f85a18fcb970d8b78e74288aa6add62d916
P2860
Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial.